Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 18:3:5.
doi: 10.1186/s40695-017-0023-9. eCollection 2017.

Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

Catherine Kim  1 , Yuanyuan Pan  2 , Barbara H Braffett  2 , Valerie L Arends  3 , Michael W Steffes  3 , Hunter Wessells  4 , Aruna V Sarma  5 ; DCCT/EDIC Research Group
Affiliations

Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

Catherine Kim et al. Womens Midlife Health. .

Abstract

Background: Reproductive age may be a risk factor for vascular disease. Anti-Müllerian hormone (AMH) is produced by viable ovarian follicles and reflects reproductive age. We examined whether AMH concentrations were associated with markers of subclinical cardiovascular disease (CVD) and kidney disease among women with type 1 diabetes.

Methods: We performed a cross-sectional analysis of the Epidemiology of Diabetes Interventions and Complications Study. Participants included women with type 1 diabetes and ≥1 AMH measurement (n = 390). In multivariable regression models which adjusted for repeated measures, we examined the associations between AMH with CVD risk factors, estimated glomerular filtration rate, and albumin excretion ratio. We also examined whether initial AMH concentrations were associated with the presence of any coronary artery calcification (CAC) or carotid intima media thickness (cIMT).

Results: After adjustment for age, AMH was not associated with waist circumference, blood pressure, lipid profiles, or renal function. Higher initial AMH concentrations had borderline but non-significant associations with the presence of CAC after adjustment for age (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.00, 1.16) which were minimally altered by addition of other CVD risk factors, although women in the 3rd quartile of AMH had lower odds of CAC than women in the lowest quartile (OR 0.40, 95% CI 0.17, 0.94). After adjustment for age, higher AMH was associated with statistically significant but only slightly higher cIMT (0.005 mm, p = 0.0087) which was minimally altered by addition of other CVD risk factors.

Conclusions: Among midlife women with type 1 diabetes, AMH has slight but significant associations with subclinical measures of atherosclerosis. Future studies should examine whether these associations are clinically significant.

Trial registration: NCT00360815 and NCT00360893 Study Start Date April 1994.

Keywords: Anti-Müllerian hormone; Coronary artery calcification; Ovarian reserve; Type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

An institutional review board at each site (n = 25) approved all study procedures, and written informed consent was obtained from study participants prior to assessments.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Flow chart of study participants
See this image and copyright information in PMC

References

    1. Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R, et al. Executive summary of the stages of reproductive aging workshop + 10; addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168. doi: 10.1210/jc.2011-3362. - DOI - PMC - PubMed
    1. Wellons M, Ouyang P, Schreiner P, Herrington D, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis (MESA) Menopause. 2012;19(10):1081–1087. doi: 10.1097/gme.0b013e3182517bd0. - DOI - PMC - PubMed
    1. Sjoberg L, Pitkaniemi J, Harjutsalo V, Haapala L, Tiitinen A, Tuomilehto J, et al. Menopause in women with type 1 diabetes. Menopause. 2011;18(2):158–163. - PubMed
    1. de Kat A, Broekmans F, Laven J, van der Schouw Y. Anti-Mullerian hormone as a marker of ovarian reserve in relation to cardiometabolic health: a narrative review. Maturitas. 2015;80:251–257. doi: 10.1016/j.maturitas.2014.12.010. - DOI - PubMed
    1. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen C, Jensen R, et al. Changes in anti-Mullerian hormone (AMH) throughout the lifespan: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010;95:5357–5364. doi: 10.1210/jc.2010-1207. - DOI - PubMed

Associated data